BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11408926)

  • 1. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
    De Lédinghen V; Monvoisin A; Neaud V; Krisa S; Payrastre B; Bedin C; Desmoulière A; Bioulac-Sage P; Rosenbaum J
    Int J Oncol; 2001 Jul; 19(1):83-8. PubMed ID: 11408926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase.
    Monvoisin A; Neaud V; De Lédinghen V; Dubuisson L; Balabaud C; Bioulac-Sage P; Desmoulière A; Rosenbaum J
    J Hepatol; 1999 Mar; 30(3):511-8. PubMed ID: 10190737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.
    Gao F; Deng G; Liu W; Zhou K; Li M
    Oncol Rep; 2017 Feb; 37(2):1203-1211. PubMed ID: 28075467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
    Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
    Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR
    Tumori; 2008; 94(4):523-30. PubMed ID: 18822689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
    Shi MD; Liao YC; Shih YW; Tsai LY
    Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: mechanisms of action.
    Tsai PC; Chu CL; Tseng CH; Chen YL; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):716-26. PubMed ID: 24909202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts.
    Godichaud S; Si-Tayeb K; Augé N; Desmoulière A; Balabaud C; Payrastre B; Nègre-Salvayre A; Rosenbaum J
    Int J Biochem Cell Biol; 2006; 38(4):629-37. PubMed ID: 16343977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
    Zhang Q; Tang X; Lu QY; Zhang ZF; Brown J; Le AD
    Mol Cancer Ther; 2005 Oct; 4(10):1465-74. PubMed ID: 16227395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells.
    Tacchini L; Dansi P; Matteucci E; Desiderio MA
    Carcinogenesis; 2001 Sep; 22(9):1363-71. PubMed ID: 11532856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
    Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
    Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.